Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetology & Metabolic Syndrome
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

GIPR rs1800437 polymorphism: prevalence and possible associations with metabolic syndrome-related diseases in a Brazilian urban population

Authors: Alexandro Marcio da Silva Mattos, Natasha Guimarães Ludwig, Gustavo Kendy Camargo Koga, Sarah Conchon Costa, Marla Karine Amarante, Tânia Longo Mazzuco

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

Glucose-dependent insulinotropic polypeptide receptor (GIPR) is mainly found in the pancreatic beta cells but has systemic distribution and function. Some genetic GIPR variants were recently associated with obesity, diabetes and insulin resistance. Few studies had studied the genetic epidemiology of the GIPR, mainly in Europe. …
Metadata
Title
GIPR rs1800437 polymorphism: prevalence and possible associations with metabolic syndrome-related diseases in a Brazilian urban population
Authors
Alexandro Marcio da Silva Mattos
Natasha Guimarães Ludwig
Gustavo Kendy Camargo Koga
Sarah Conchon Costa
Marla Karine Amarante
Tânia Longo Mazzuco
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A200

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue

Meeting abstract

Risk factors for gestational diabetes mellitus in a sample of pregnant women diagnosed with the disease

Meeting abstract

Prevalence of overweight, obesity and metabolic syndrome in HIV-infected patients

Meeting abstract

Comparison of two techniques for evaluation of pancreatic islet viability: flow cytometry and FDA/PI staining

Meeting abstract

Short message service phone reminder as an important tool to reduce absenteeism for atendance at healthcare appointments

Meeting abstract

Timing and type of alcohol consumption and the metabolic syndrome: ELSA-Brasil

Meeting abstract

Indentification of single base mutations in the GCK gene of patients with diagnosis of MODY2
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits